We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.62%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$720M
AUM Growth
-$59.6M
(-7.6%)
Cap. Flow
-$36.5M
Cap. Flow
% of AUM
-5.06%
Top 10 Holdings %
Top 10 Hldgs %
17.21%
Holding
510
New
74
Increased
122
Reduced
203
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$4.08M |
| 2 |
JBTM
JBT Marel
JBTM
|
+$3.91M |
| 3 |
PRSU
Pursuit Attractions and Hospitality Inc
PRSU
|
+$3.66M |
| 4 |
Northern Oil and Gas
NOG
|
+$3.45M |
| 5 |
Devon Energy
DVN
|
+$3.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DEN
Denbury Inc.
DEN
|
+$7.07M |
| 2 |
Reliance Steel & Aluminium
RS
|
+$5.93M |
| 3 |
CHX
ChampionX
CHX
|
+$4.74M |
| 4 |
Accenture
ACN
|
+$4.11M |
| 5 |
On Holding
ONON
|
+$3.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Consumer Discretionary | 17.64% |
| 3 | Industrials | 15.79% |
| 4 | Healthcare | 11.67% |
| 5 | Financials | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Runway Growth Finance
RWAY
$230M
| $422K | 0.06% |
32,933
-27,111
| -45% | -$349K |
|
|
CCC
302
CCC Intelligent Solutions
CCC
$3.52B
| $418K | 0.06% |
+31,335
| New | +$344K |
|
303
Carpenter Technology
CRS
$28.4B
| $417K | 0.06% |
+6,205
| New | +$376K |
|
304
Freshworks
FRSH
$3.02B
| $414K | 0.06% |
+20,808
| New | +$414K |
|
305
nLIGHT
LASR
$3.7B
| $412K | 0.06% |
39,657
+8,041
| +25% | +$98.2K |
|
306
McKesson
MCK
$100B
| $404K | 0.06% |
929
+446
| +92% | +$188K |
|
307
Adecoagro
AGRO
$1.47B
| $404K | 0.06% |
+34,553
| New | +$373K |
|
308
Hyster-Yale Materials Handling
HY
$584M
| $403K | 0.06% |
9,046
-23,969
| -73% | -$1.11M |
|
309
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
| $402K | 0.06% |
8,065
| – | – |
|
310
S&P Global
SPGI
$130B
| $400K | 0.06% |
1,096
+40
| +4% | +$15.7K |
|
311
Barclays
BCS
$95.1B
| $399K | 0.06% |
51,260
-4,300
| -8% | -$33.4K |
|
312
Applied Materials
AMAT
$393B
| $399K | 0.06% |
2,884
-58
| -2% | -$8.32K |
|
313
KLA
KLAC
$257B
| $397K | 0.06% |
8,660
-130
| -1% | -$6.24K |
|
314
Chipotle Mexican Grill
CMG
$42.3B
| $396K | 0.05% |
+10,800
| New | +$421K |
|
315
Fortinet
FTNT
$113B
| $394K | 0.05% |
+6,712
| New | +$444K |
|
316
Vistra
VST
$53.2B
| $393K | 0.05% |
11,859
-14,808
| -56% | -$445K |
|
317
PDF Solutions
PDFS
$1.94B
| $393K | 0.05% |
12,142
-10,202
| -46% | -$391K |
|
318
ACM Research
ACMR
$5.28B
| $393K | 0.05% |
+21,685
| New | +$322K |
|
319
Cigna
CI
$77.1B
| $392K | 0.05% |
+1,372
| New | +$391K |
|
320
Intuitive Surgical
ISRG
$128B
| $390K | 0.05% |
1,333
+84
| +7% | +$26.2K |
|
|
PR
321
Permian Resources
PR
$17.3B
| $389K | 0.05% |
+27,883
| New | +$351K |
|
322
Fastly Inc
FSLY
$3.09B
| $385K | 0.05% |
+20,102
| New | +$392K |
|
323
Vertex Pharmaceuticals
VRTX
$123B
| $380K | 0.05% |
1,092
+8
| +0.7% | +$2.8K |
|
324
Stryker
SYK
$129B
| $378K | 0.05% |
1,384
+23
| +2% | +$6.59K |
|
325
Portillo's
PTLO
$336M
| $373K | 0.05% |
24,212
-87,646
| -78% | -$1.71M |
|
Similar funds
VFG
SLG
KCP
UAG
PS
RPAM
BBI
SSG
Advisory Research's Q3 2023 Portfolio in Review
As of Q3 2023, Advisory Research held 510 positions worth $720M, down 7.6% from $780M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Advisory Research withdrew a net $36.5M in Q3 2023, closing 86 positions and reducing 203 holdings. Its most notable exit was Livent Corporation, an estimated $2.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Advisory Research opened a new position in JBT Marel worth $3.67M.
- Advisory Research's largest Q3 2023 buy was JBT Marel: 34,900 shares worth $3.67M.
- Advisory Research added most to GSK in Q3 2023, an estimated $4.08M increase.
- Advisory Research's biggest Q3 2023 reduction was Denbury Inc., cutting an estimated $7.07M.
- Advisory Research fully exited Livent Corporation in Q3 2023, selling an estimated $2.81M.
- Advisory Research's ten largest holdings make up 17% of its $720M portfolio in Q3 2023.
- Advisory Research opened 74 new positions and closed 86 in Q3 2023.
- Advisory Research's portfolio value fell 7.6% quarter-over-quarter to $720M.
Based on Advisory Research's 13F filing for Q3 2023, filed 13 Nov 2023.